330838-52-3,
Tranexamic acid related compound C,
4-(Aminomethyl)cyclohex-1-enecarboxylic acid,
4-(aminomethyl)cyclohex-1-ene-1-carboxylic acid,
1,2-Didehydro tranexamic acid,
Tranexamic acid impurity C [EP],
Tranexamic acid related compound C [USP],
Tranexamic acid related compound C RS [USP],
7-AMC,
(RS)-4-(Aminomethyl)cyclohex-1-enecarboxylic acid,
1-Cyclohexene-1-carboxylic acid, 4-(aminomethyl)-,
FCH880337,
MFCD10001448,
STL450970,
AKOS006305238,
ACM330838523,
SC-93864,
FT-0661904,
EN300-207462,
1-Cyclohexene-1-carboxylicacid,4-(aminomethyl)-(9CI),
4-(AMINOMETHYL)-1-CYCLOHEXENE-1-CARBOXYLIC ACID,
4-(Aminomethyl)-1-cyclohexene-1-carboxylic Acid (Tranexamic acid Impurity),
Coumarin 120,
Coumarin 440,
4-Methyl-7-aminocoumarin,
7-Amino-4-methylcoumarin,
UNII-5WP87419XG,
5WP87419XG,
NSC 45796,
CID9920436,
(4-Methyl-2-oxo-2H-chromen-7-yl)amine,
7-amino-4-methyl-2H-1-Benzopyran-2-one,
4-(aminomethyl)cyclohexene-1-carboxylic Acid,
C 120,
1-Cyclohexene-1-carboxylic acid, 4-(aminomethyl)- (9CI),
26093-31-2,